Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

PRX

Pharmacutical (PRX)

Pharmaceutical Companies
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:PRX
DateTimeSourceHeadlineSymbolCompany
08/10/20158:10AMDow Jones NewsEndo International Beats Revenue, Earnings TargetsNYSE:PRXPharmaceutical Companies
05/26/20159:19AMPR Newswire (US)Par Specialty Pharmaceuticals Launches Cortisporin®-TC Otic SuspensionNYSE:PRXPharmaceutical Companies
05/18/20153:09PMDow Jones NewsStocks Gain; Dow, S&P 500 Flirt With RecordsNYSE:PRXPharmaceutical Companies
05/18/201512:50PMDow Jones NewsStocks Gain; Dow, S&P 500 Flirt With RecordsNYSE:PRXPharmaceutical Companies
05/18/201511:18AMDow Jones NewsEndo to Buy Generics Maker Par Pharma for $8 Billion -- 4th UpdateNYSE:PRXPharmaceutical Companies
05/18/201510:53AMDow Jones NewsU.S. Stocks Waver After Dow Touches RecordNYSE:PRXPharmaceutical Companies
05/18/201510:05AMDow Jones NewsEndo to Buy Generics Maker Par Pharma for $8 Billion -- 3rd UpdateNYSE:PRXPharmaceutical Companies
05/18/20159:37AMDow Jones NewsU.S. Stocks Edge Higher; Dow Hits RecordNYSE:PRXPharmaceutical Companies
05/18/20158:20AMDow Jones NewsEndo to Buy Par PharmaNYSE:PRXPharmaceutical Companies
05/18/20157:53AMDow Jones NewsEndo to Buy Generics Maker Par Pharma for $8 Billion -- 2nd UpdateNYSE:PRXPharmaceutical Companies
05/18/20157:50AMDow Jones NewsU.S. Stock Futures Edge LowerNYSE:PRXPharmaceutical Companies
05/18/20156:44AMDow Jones NewsEndo to Buy Generics Maker Par Pharma for About $8 Billion -- UpdateNYSE:PRXPharmaceutical Companies
03/18/20143:32PMEdgar (US Regulatory)Annual Report (10-k)NYSE:PRXPharmaceutical Companies
02/20/20141:45PMEdgar (US Regulatory)Current Report Filing (8-k)NYSE:PRXPharmaceutical Companies
02/19/20142:08PMEdgar (US Regulatory)Definitive Materials Filed by Investment Companies. (497)NYSE:PRXPharmaceutical Companies
02/19/20142:03PMEdgar (US Regulatory)Current Report Filing (8-k)NYSE:PRXPharmaceutical Companies
11/12/20137:06AMEdgar (US Regulatory)Quarterly Report (10-q)NYSE:PRXPharmaceutical Companies
08/28/20135:01AMEdgar (US Regulatory)Notice of Effectiveness (effect)NYSE:PRXPharmaceutical Companies
08/28/20135:01AMEdgar (US Regulatory)Notice of Effectiveness (effect)NYSE:PRXPharmaceutical Companies
08/27/201310:36AMEdgar (US Regulatory)Semi-annual Report (management Company) (nsar-a)NYSE:PRXPharmaceutical Companies
08/27/201310:36AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NYSE:PRXPharmaceutical Companies
08/15/20137:13AMEdgar (US Regulatory)Securities Registration: Business Combination (s-4)NYSE:PRXPharmaceutical Companies
02/11/201310:55AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NYSE:PRXPharmaceutical Companies
10/16/20127:58AMEdgar (US Regulatory)Termination of Registration of a Class of Security under Section 12(g) (15-12G)NYSE:PRXPharmaceutical Companies
10/12/20127:30AMEdgar (US Regulatory)Termination of Registration of a Class of Security under Section 12(g) (15-12G)NYSE:PRXPharmaceutical Companies
10/10/20129:59AMEdgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NYSE:PRXPharmaceutical Companies
10/09/201210:03AMEdgar (US Regulatory)Post-Effective Amendment to an S-8 filing (S-8 POS)NYSE:PRXPharmaceutical Companies
10/09/201210:02AMEdgar (US Regulatory)Post-Effective Amendment to an S-8 filing (S-8 POS)NYSE:PRXPharmaceutical Companies
10/09/201210:01AMEdgar (US Regulatory)Post-Effective Amendment to an S-8 filing (S-8 POS)NYSE:PRXPharmaceutical Companies
10/09/201210:00AMEdgar (US Regulatory)Post-Effective Amendment to an S-8 filing (S-8 POS)NYSE:PRXPharmaceutical Companies
 Showing the most relevant articles for your search:NYSE:PRX